Nanotechnology diagnostics for infectious diseases prevalent in developing countries.
about
Advanced Nanobiomaterials: Vaccines, Diagnosis and Treatment of Infectious DiseasesAnti-HIV-1 nanotherapeutics: promises and challenges for the futureAn emerging interface between life science and nanotechnology: present status and prospects of reproductive healthcare aided by nano-biotechnologyTrimodal Therapy: Combining Hyperthermia with Repurposed Bexarotene and Ultrasound for Treating Liver Cancer.Emerging technologies for monitoring drug-resistant tuberculosis at the point-of-careRethinking approaches to improve the utilization of nucleic acid amplification tests for detection and characterization of influenza A in diagnostic and reference laboratories.Current developments and future perspectives for TB diagnostics.Multiplexed enrichment and detection of malarial biomarkers using a stimuli-responsive iron oxide and gold nanoparticle reagent systemField-portable wide-field microscopy of dense samples using multi-height pixel super-resolution based lensfree imaging.Multicolored silver nanoparticles for multiplexed disease diagnostics: distinguishing dengue, yellow fever, and Ebola viruses.Biomarker discovery by novel sensors based on nanoproteomics approaches.Mathematical framework for activity-based cancer biomarkers.Tackling HIV through robust diagnostics in the developing world: current status and future opportunities.Sensitivity and specificity of PS/AA-modified nanoparticles used in malaria detection.Recent advancements in optical DNA biosensors: exploiting the plasmonic effects of metal nanoparticles.Lab-on-paper-based devices using chemiluminescence and electrogenerated chemiluminescence detection.AuNPs for identification of molecular signatures of resistance.The future for early-stage tuberculosis drug discoveryApplication of nanodiagnostics in point-of-care tests for infectious diseasesRapid diagnostic tests for malaria: past, present and future.Iron oxide magnetic nanoparticles as antimicrobials for therapeutics.A broad-range method to detect genomic DNA of multiple pathogenic bacteria based on the aggregation strategy of gold nanorods.High sensitive and direct fluorescence detection of single viral DNA sequences by integration of double strand probes onto microgels particles.Maskless imaging of dense samples using pixel super-resolution based multi-height lensfree on-chip microscopy.Protein A-conjugated iron oxide nanoparticles for separation of Vibrio cholerae from water samples.A plasmonic DNAzyme strategy for point-of-care genetic detection of infectious pathogens.Simulated environmental risk estimation of engineered nanomaterials: a case of cosmetics in Johannesburg City.Photoinduced Dynamics and Toxicity of a Cancer Drug in Proximity of Inorganic Nanoparticles under Visible Light.Peroxidyme-Amplified Radical Chain Reaction (PARCR): Visible Detection of a Catalytic Reporter.Gold nanoparticle-based colorimetric biosensors.Rapidly prototyped multi-scale electrodes to minimize the voltage requirements for bacterial cell lysis.Intestinal Permeability of Artesunate-Loaded Solid Lipid Nanoparticles Using the Everted Gut Method.Microfluidic Platforms for Evaluation of Nanobiomaterials: A Review
P2860
Q26744748-61EEB3A1-1E49-423E-8DA4-C0E9B1CC9F57Q26828464-4EB30DD4-4907-4676-AF0E-662C7195CAC5Q28658189-D49A345E-87FC-4A9B-BFA6-9605E6F561F8Q30369255-2EA83D4C-6173-4B05-9A3E-35B9218F99D4Q30397647-98805E87-90DA-4C7C-9682-8F615F302D44Q30410029-69D7C0F5-A85F-4708-B570-0115F55DD40AQ30410962-F444ACEF-0600-4394-98DB-A249136CF0C9Q33857558-A7CA948D-4506-4449-BB42-47D35DFC0E07Q34158987-E4D67453-62B1-4D2D-B7A6-3032906B7FF4Q35222184-8FDB633B-D1A7-4D5F-AABC-4C189E4CA12EQ35831485-227C0FA9-7B1E-46DF-9351-E29A341AF56AQ36179245-7C7A0E55-4AD7-419F-A788-BE96A0CEE307Q37530464-33AA2EC9-A384-4667-8012-40804391A317Q37566858-5D7FB71B-CCB5-427E-87D2-C973736A27BBQ37806967-933F7D56-5D76-4B85-AC42-B7324E084439Q38202551-99BB011A-9F0D-4DE7-A9AA-B0C3C06F0EA3Q38249184-223C7B8F-9F14-493F-9CAA-F39720FE3453Q38358621-6D6B0011-B328-41D3-8FCE-CCAC8B45DFB6Q38652389-07E61671-474E-4589-8E51-106F994165D9Q38803532-823A7019-EC37-4348-9A14-6ABC33A7B913Q39342006-1FAA8B35-8230-45CD-9079-02593E6761D4Q39579133-437DBECD-D6F5-4ECB-8573-609B47750A5FQ40995919-FFCA4144-A9E6-45E4-8652-BE1C10DF2EE8Q42091095-FC17EB87-821C-4996-88F0-EDA9E7F9B865Q42180762-7883EE2E-ED46-4EDE-8C02-4F661DA41257Q42275458-559D445D-1966-477C-BD33-4574AA18DC1CQ43762664-D4524808-8E32-4466-9D67-ACA4975EADFFQ46640057-995A934C-C5C6-422B-9570-3433EF0F63E9Q48156826-604970FE-FC1F-4965-AE1B-0B95CDE52E09Q50052032-0E475EA3-9EFC-4AA6-A151-B9CBD28A509FQ51501007-E54640B3-ED4F-4D45-9D96-031C52FC2420Q55520069-D8B21418-A2DA-484C-82AA-CE19E0D5F46EQ58910627-C1124918-B5A1-4227-9F5D-2F8F7F2B889B
P2860
Nanotechnology diagnostics for infectious diseases prevalent in developing countries.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Nanotechnology diagnostics for infectious diseases prevalent in developing countries.
@ast
Nanotechnology diagnostics for infectious diseases prevalent in developing countries.
@en
type
label
Nanotechnology diagnostics for infectious diseases prevalent in developing countries.
@ast
Nanotechnology diagnostics for infectious diseases prevalent in developing countries.
@en
prefLabel
Nanotechnology diagnostics for infectious diseases prevalent in developing countries.
@ast
Nanotechnology diagnostics for infectious diseases prevalent in developing countries.
@en
P2093
P1476
Nanotechnology diagnostics for infectious diseases prevalent in developing countries.
@en
P2093
Supratim Giri
Tanya S Hauck
Warren C W Chan
P304
P356
10.1016/J.ADDR.2009.11.015
P407
P577
2009-11-24T00:00:00Z